Close
24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.

Read the full press release published by the ALBA Synchrotron

More news

10/06/2015 The Barcelona Synchrotron Park in the SmartReFlex European project 01/06/2015 SENER and ALBA sign a technology transfer agreement 28/05/2015 Synchrotron light applications for the pharmaceutical industry 20/05/2015 Financial Times ranks ESADE 7th worldwide in open executive education programmes 14/05/2015 Joint promotion in Korea of the Barcelona Synchrotron Park and the Parc Científic de Barcelona 07/05/2015 The UAB ranks well
32 33 34 35 36 37 38 39 40 41 42